ArticleBlood advances2022

Antibody response to mRNA vaccination for COVID-19 in patients with AML receiving hypomethylating agents alone or with venetoclax.

Anna Candoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.